NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $3,184,000 | -45.3% | 89,000 | -60.3% | 0.92% | -45.9% |
| Q3 2014 | $5,824,000 | +163.1% | 224,000 | +234.3% | 1.70% | +159.5% |
| Q2 2014 | $2,214,000 | -55.7% | 67,000 | -59.9% | 0.66% | -56.2% |
| Q1 2014 | $4,997,000 | -31.4% | 166,970 | -30.4% | 1.50% | -47.4% |
| Q4 2013 | $7,286,000 | – | 240,000 | – | 2.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 549,425 | $16,680,000 | 6.89% |
| Opaleye Management Inc. | 205,000 | $5,945,000,000 | 4.67% |
| Rhenman & Partners Asset Management AB | 240,000 | $7,286,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 1,774,919 | $53,887,000 | 2.32% |
| Eventide Asset Management | 242,700 | $7,368,000 | 2.27% |
| OAK RIDGE INVESTMENTS LLC | 2,713,717 | $82,389,000 | 2.16% |
| First Light Asset Management, LLC | 68,245 | $2,072,000 | 1.76% |
| Broadfin Capital, LLC | 400,000 | $12,144,000 | 1.60% |
| Cupps Capital Management, LLC | 748,175 | $22,714,000 | 1.54% |
| FCG ADVISORS, LLC | 70,651 | $2,145,000 | 1.45% |